160 related articles for article (PubMed ID: 28414195)
1. Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Matsuda K; Namiki T; Ueno M; Hashimoto T; Hanafusa T; Yokozeki H
Eur J Dermatol; 2017 Jun; 27(3):323-325. PubMed ID: 28414195
[No Abstract] [Full Text] [Related]
2. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
3. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
Kim J; Kim SH; Lee MG; Chung KY; Kim DS
Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
[No Abstract] [Full Text] [Related]
4. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
Komatsu-Fujii T; Ogawa M; Nonoyama S; Fukumoto T; Tanabe H
Eur J Dermatol; 2021 Feb; 31(1):98-99. PubMed ID: 33586655
[No Abstract] [Full Text] [Related]
5. TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.
Miyagawa F; Sugano Y; Sho M; Asada H
Eur J Dermatol; 2017 Dec; 27(6):646-647. PubMed ID: 28721931
[No Abstract] [Full Text] [Related]
6. Unilateral Capecitabine-related Hand-foot Syndrome.
Matsuda S; Koketsu H; Hayakawa M; Nagata N
Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
[No Abstract] [Full Text] [Related]
7. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
8. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
9. Safety of alternate-day treatment with TS-1
Nishiyama Y; Fukuyama Y; Maruo T; Yoda S; Iwano M; Kawarai S; Kayanuma H; Orito K
J Vet Med Sci; 2021 Aug; 83(8):1206-1211. PubMed ID: 34148911
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
11. Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
Koda K; Miyauchi H; Kosugi C; Kaiho T; Takiguchi N; Kobayashi S; Maruyama T; Matsubara H;
Anticancer Res; 2016 Oct; 36(10):5325-5331. PubMed ID: 27798895
[TBL] [Abstract][Full Text] [Related]
12. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of tegafur-gimeracil-oteracil potassium (TS-1) for metastatic breast cancer: a single-center retrospective study.
Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Tsuji E; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2577-82. PubMed ID: 25596051
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Wang T; Zhang SF; Qiu MQ; Li QL
Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
[TBL] [Abstract][Full Text] [Related]
16. [A case of 5-fluorouracil-induced hyperammmonia after chemotherapy for metastatic colon cancer].
Nakamura M; Kobashikawa K; Tamura J; Takaki R; Ohshiro M; Matayoshi R; Hirata T; Kinjyo F; Fujita J
Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1744-50. PubMed ID: 19966516
[TBL] [Abstract][Full Text] [Related]
17. Small-vessel vasculitis following treatment with combination 5-fluorouracil/folinic acid and oxaliplatin.
Hill SE; Phillips R; Francis N; Agnew K
Clin Exp Dermatol; 2009 Jan; 34(1):103-5. PubMed ID: 19076812
[No Abstract] [Full Text] [Related]
18. A Rare Case of Reversible Cardiac Dysfunction Associated with Tegafur/Gimeracil/Oteracil (S-1) Therapy.
Oyakawa T; Hua Z; Ebihara A; Shiga T
Int Heart J; 2021 May; 62(3):700-705. PubMed ID: 33994512
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of colonic cancer].
Block S
Soins; 2010 Mar; (743):46. PubMed ID: 20423037
[No Abstract] [Full Text] [Related]
20. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
